Artwork

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Head and Neck Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Head and Neck Cancer

1:31:08
 
Share
 

Manage episode 421381970 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Featuring perspectives from Ms Meetal Dharia, Dr Robert L Ferris, Dr Robert Haddad and Ms Lynsey P Teulings, including the following topics:

  • Introduction (0:00)
  • The Biology of Head and Neck Cancer (15:41)
  • The Multidisciplinary Treatment of Head and Neck Cancer (18:14)
  • Ongoing Screening and Prevention After Potentially Curative Therapy for Head and Neck Cancer (33:03)
  • Radiation Therapy and Chemotherapy Side Effects (41:02)
  • The Potential Short- and Long-Term Effects of Surgery for Head and Neck Cancer (49:50)
  • Emerging Treatment Strategies Aimed at Improving Outcomes Associated with Localized or Locally Advanced Head and Neck Cancer (56:46)
  • Tolerability Considerations with Xevinapant (1:06:13)
  • The Established Role of Anti-PD-1/PD-L1 Antibodies in Therapy for Advanced Head and Neck Cancer (1:17:35)
  • Newly Approved Immunotherapeutic Strategies for Nasopharyngeal Carcinoma (1:19:27)
  • The Tolerability of Immune Checkpoint Inhibitors (1:24:09)

NCPD information and select publications

  continue reading

1412 episodes

Artwork
iconShare
 
Manage episode 421381970 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Featuring perspectives from Ms Meetal Dharia, Dr Robert L Ferris, Dr Robert Haddad and Ms Lynsey P Teulings, including the following topics:

  • Introduction (0:00)
  • The Biology of Head and Neck Cancer (15:41)
  • The Multidisciplinary Treatment of Head and Neck Cancer (18:14)
  • Ongoing Screening and Prevention After Potentially Curative Therapy for Head and Neck Cancer (33:03)
  • Radiation Therapy and Chemotherapy Side Effects (41:02)
  • The Potential Short- and Long-Term Effects of Surgery for Head and Neck Cancer (49:50)
  • Emerging Treatment Strategies Aimed at Improving Outcomes Associated with Localized or Locally Advanced Head and Neck Cancer (56:46)
  • Tolerability Considerations with Xevinapant (1:06:13)
  • The Established Role of Anti-PD-1/PD-L1 Antibodies in Therapy for Advanced Head and Neck Cancer (1:17:35)
  • Newly Approved Immunotherapeutic Strategies for Nasopharyngeal Carcinoma (1:19:27)
  • The Tolerability of Immune Checkpoint Inhibitors (1:24:09)

NCPD information and select publications

  continue reading

1412 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide